Article
Lymphokine-activated killer (LAK) cells discriminate between Epstein-Barr virus (EBV)-positive Burkitt's lymphoma cells.
International journal of cancer - 15 Sept 1990
Misko I S, Schmidt C, Martin N, Moss D J, Sculley T B, Burrows S, Burman K J
Abstract excerpt
We have generated in vitro lymphokine-activated killer (LAK) cells from healthy donors by stimulating their mononuclear leukocytes with recombinant interleukin-2 (rIL-2) (100 U/ml). After 6 days in culture, the lytic properties of the LAK cells were analyzed in the 51Cr-release assay by utilizing a target panel of 6 paired lines consisting of an Epstein-Barr virus (EBV)-positive Burkitt's lymphoma (BL) cell line...
Topics
- Animals
- Antibodies, Monoclonal
- Burkitt Lymphoma
- Cell Line
- Cytotoxicity, Immunologic
- Herpesvirus 4, Human
- Humans
- Immunologic Surveillance
- Interleukin-2
- Killer Cells, Lymphokine-Activated
